BioMed Realty Trust Completes $350 Million Financing for Center for Life Science...

BioMed Realty Trust Completes $350 Million Financing for Center for Life
Science | Boston

SAN DIEGO, June 29 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE:
BMR) announced today the closing of a new $350 million loan with John Hancock
Life Insurance Company, TIAA-CREF, and Westdeutsche ImmobilienBank AG. The
five year loan is secured by a single property - the Center for Life Science |
Boston, a newly constructed 700,000+ square foot state-of-the-art research
facility that recently received Gold LEED(R) certification from the U.S. Green
Building Council.

"One of the hallmarks of BioMed's strategy has been proactive management of
its capital structure, and the timely completion of the financing for the
Center for Life Science | Boston is a prime example of our team's ability to
execute on this strategy," said Kent Griffin, President and Chief Financial
Officer of BioMed. "In combination with our recent secondary common stock
offering, which raised gross proceeds of $174.3 million, we have positioned
BioMed well for continued long-term success in the execution of our business
plan of acquiring, developing, owning and operating world-class research
facilities in the core life science markets. We want to thank our lenders for
their recognition of the world-class nature of the facility, the strength of
its tenancy and especially their commitment to successfully completing this
loan in a still challenging global credit environment."

The Center for Life Science | Boston, located in the heart of Boston's
Longwood Medical Area, is surrounded by exceptional life science research
institutions, hospitals and biotechnology and pharmaceutical companies,
including Harvard Medical School, Brigham and Women's Hospital, and Merck
Research Laboratories Boston. Additionally, the Center for Life Science|
Boston possesses a premier tenant roster, including Beth Israel Deaconess
Medical Center, Children's Hospital Boston, Dana-Farber Cancer Institute,
Immune Disease Institute and Kowa Company, Ltd.

The $350 million loan bears interest at 7.75% per annum and matures in June
2014. Proceeds from the loan were used to repay a portion of an existing
$507.1 million secured construction loan on the property. BioMed paid down
the remaining balance of the existing secured construction loan by drawing on
the company's unsecured line of credit. The new mortgage financing for the
Center for Life Science | Boston successfully addresses the last of BioMed's
debt maturities in 2009.

About BioMed Realty Trust
BioMed Realty Trust, Inc. is a real estate investment trust (REIT) focused on
Providing Real Estate to the Life Science Industry(R). The company's tenants
primarily include biotechnology and pharmaceutical companies, scientific
research institutions, government agencies and other entities involved in the
life science industry. BioMed Realty Trust owns or has interests in 69
properties, representing 112 buildings with approximately 10.5 million
rentable square feet, including approximately 640,000 square feet of
development in progress. The company also owns undeveloped land parcels
adjacent to existing properties that it estimates can support up to 1.4
million rentable square feet. The company's properties are located
predominantly in the major U.S. life science markets of Boston, San Diego, San
Francisco, Seattle, Maryland, Pennsylvania and New York/New Jersey, which have
well-established reputations as centers for scientific research.

About LEED(R)
The Leadership in Energy and Environmental Design (LEED(R)) Green Building
Rating System(TM) encourages and accelerates global adoption of sustainable
green building and development practices through the creation and
implementation of universally understood and accepted tools and performance
criteria. LEED(R) is a third-party certification program and the nationally
accepted benchmark for the design, construction and operation of high
performance green buildings. LEED(R) gives building owners and operators the
tools they need to have an immediate and measurable impact on their buildings'
performance.

TIAA-CREF Individual & Institutional Services, LLC, and Teachers Personal
Investors Services, Inc., members FINRA, distribute securities products.

This press release contains forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995 based on current
expectations, forecasts and assumptions that involve risks and uncertainties
that could cause actual outcomes and results to differ materially. These
risks and uncertainties include, without limitation: general risks affecting
the real estate industry (including, without limitation, the inability to
enter into or renew leases, dependence on tenants' financial condition, and
competition from other developers, owners and operators of real estate);
adverse economic or real estate developments in the life science industry or
the company's target markets; risks associated with the availability and terms
of financing, the use of debt to fund acquisitions and developments, and the
ability to refinance indebtedness as it comes due; failure to manage
effectively the company's growth and expansion into new markets, or to
complete or integrate acquisitions and developments successfully; risks and
uncertainties affecting property development and construction; risks
associated with downturns in the national and local economies, increases in
interest rates, and volatility in the securities markets; potential liability
for uninsured losses and environmental contamination; risks associated with
the company's potential failure to qualify as a REIT under the Internal
Revenue Code of 1986, as amended, and possible adverse changes in tax and
environmental laws; and risks associated with the company's dependence on key
personnel whose continued service is not guaranteed. For a further list and
description of such risks and uncertainties, see the reports filed by the
company with the Securities and Exchange Commission, including the company's
most recent annual report on Form 10-K and quarterly reports on Form 10-Q.
The company disclaims any intention or obligation to update or revise any
forward-looking statements, whether as a result of new information, future
events or otherwise.

SOURCE BioMed Realty Trust, Inc.

Rick Howe, Director, Corporate Communications of BioMed Realty Trust, Inc.,
+1-858-207-5859, richard.howe@biomedrealty.com